Relation of the expression of transcriptional factor TFAP2B to that of adipokines in subcutaneous and omental adipose tissues

Obesity

Volumn 18, Issue 7, 2010, Pages 1277-1282

  Ugi, Satoshi ^a   Nishio, Yoshihiko ^a   Yamamoto, Hiroshi ^a   Ikeda, Kazuhiro ^a   Kobayashi, Masaaki ^b   Tsukada, Shuichi ^b   Kondo, Motoyuki ^a   Morino, Katsutaro ^a   Obata, Toshiyuki ^a   Yoshizaki, Takeshi ^a   Uzu, Takashi ^a   Naitoh, Hiroyuki ^a   Tani, Toru ^a   Maeda, Shiro ^b   Kashiwagi, Atsunori ^a   Maegawa, Hiroshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; TFAP2B PROTEIN, HUMAN; TRANSCRIPTION FACTOR AP 2; ADIPOQ PROTEIN, HUMAN;

ABDOMINAL FAT; AGED; ARTICLE; BLOOD; BODY MASS; FEMALE; GENETICS; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OMENTUM; PATHOPHYSIOLOGY; PHYSIOLOGY; SUBCUTANEOUS FAT; VERY ELDERLY;

ABDOMINAL FAT; ADIPONECTIN; AGED; AGED, 80 AND OVER; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTERLEUKIN-6; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OMENTUM; RNA, MESSENGER; SUBCUTANEOUS FAT; TRANSCRIPTION FACTOR AP-2;

EID: 77954143887     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.442     Document Type: Article

References (23)

1. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-2556.
2. Trujillo ME, Scherer PE. Adipose tissue-derived factors: impact on health and disease. Endocr Rev 2006;27:762-778.
3. Maeda S, Tsukada S, Kanazawa A et al. Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus. J Hum Genet 2005;50:283-292. (Pubitemid 41159984)
4. Tsukada S, Tanaka Y, Maegawa H et al. Intronic polymorphisms within TFAP2B regulate transcriptional activity and affect adipocytokine gene expression in differentiated adipocytes. Mol Endocrinol 2006;20: 1104-1111.
5. Tao Y, Maegawa H, Ugi S et al. The transcription factor AP-2beta causes cell enlargement and insulin resistance in 3T3-L1 adipocytes. Endocrinology 2006;147:1685-1696.
6. Ikeda K, Maegawa H, Ugi S et al. Transcription factor activating enhancer-binding protein-2beta. A negative regulator of adiponectin gene expression. J Biol Chem 2006;281:31245-31253.
7. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-1062.
8. Cowey S, Hardy RW. The metabolic syndrome: A high-risk state for cancer? Am J Pathol 2006;169:1505-1522.
9. Kerem M, Ferahkose Z, Yilmaz UT et al. Adipokines and ghrelin in gastric cancer cachexia. World J Gastroenterol 2008;14:3633-3641.
10. Cnop M, Havel PJ, Utzschneider KM et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46: 459-469.
11. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738.
12. Yatagai T, Nagasaka S, Taniguchi A et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metab Clin Exp 2003;52:1274-1278.
13. Kadowaki T, Hara K, Yamauchi T et al. Molecular mechanism of insulin resistance and obesity. Exp Biol Med (Maywood) 2003;228:1111-1117.
14. Vohl MC, Sladek R, Robitaille J et al. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes Res 2004;12:1217-1222.
15. Lihn AS, Bruun JM, He G et al. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004;219:9-15.
16. Montague C T, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 2000;49:883-888.
17. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145:2273-2282.
18. Sharma AM, Staels B. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 2007;92:386-395.
19. Ito A, Suganami T, Miyamoto Y et al. Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy. J Biol Chem 2007;282:25445-25452.
20. Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 2008;14:222-231.
21. Degawa-Yamauchi M, Moss KA, Bovenkerk JE et al. Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res 2005;13: 662-669.
22. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003;52:1779-1785.
23. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998;83:847-850.